AgingResearch.News

DNAmTL

Biomarker3 papers4 findings

Human studies associate DNAmTL with cognitive function, PhenoAge, and cholestatic liver disease, with one study showing decreased levels in primary sclerosing cholangitis.

  • Humans3

Upstream

1

Primary sclerosing cholangitis

downin humans1

1 study
  1. Primary sclerosing cholangitis decreases DNAmTL in humans (median -0.036 vs. 0.016).

    Humanscompared with controls

    Telomere attrition marks disease severity in chronic cholestatic liver diseases · Alimentary pharmacology & therapeutics · 29 Sep 2026

Primary sclerosing cholangitis →

Associations

3

Cholestatic liver disease

downin humans1

1 study
  1. Cholestatic liver disease is associated with DNAmTL in humans.

    Humans

    Telomere attrition marks disease severity in chronic cholestatic liver diseases · Alimentary pharmacology & therapeutics · 29 Sep 2026

Cholestatic liver disease →

Cognitive function

upin humans1

1 study
  1. Cognitive function is associated with DNAmTL in humans (6.39 ± 0.27 vs 5.39 ± 0.21 kb; Cohen's d = 4.15).

    Humansin Healthy Cognitive Agers aged ≥80 years maintaining MMSE = 30n = 80

    Older adults with preserved cognition show slower biological aging and longer telomeres · Aging and disease · 23 Sep 2026

PhenoAge

downin humans1

1 study
  1. DNAmTL is associated with PhenoAge in humans.

    “DNAmTL was inversely associated with both domains and did not differ significantly across domains.”

    Humansboth mitotic and early-life systemic dysregulation domainsblood

    Blood methylation clocks capture two distinct biological domains of aging · Genes · 9 Sep 2026

PhenoAge →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 3Oct 2026: 03